OVIOPEPTIDES

Exclusive Offer

Free Bacteriostatic Water

Sign up and get a free bacteriostatic water added to your next order, automatically.

Research Use OnlyGet free bacteriostatic water added to your next order when you join the list.

MOTS-c — Canada Research Brief

By Dr. Elena Morozova, PhDReviewed by Dr. Elena Morozova, PhDPublished April 11, 2026Last reviewed April 11, 20261 min read
Quick answer

MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA gene, studied preclinically for AMPK signalling, glucose homeostasis, and metabolic adaptation to exercise.

Key facts

Canonical nameMOTS-c
Alternate namesMitochondrial open reading frame of the 12S rRNA type-c, MOTSc
Drug classMitochondrial-derived peptide (metabolic signalling)
CAS number1627580-64-6
Molecular formulaC100H152N24O22S
Molecular weight2174.58 g/mol
SequenceMet-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
COA pending
Research product
US$65.00In stock
View

Discovery and context

MOTS-c was identified by Changhan Lee and colleagues at USC in 2015 through systematic bioinformatic scanning of the mitochondrial 12S rRNA gene for small open reading frames (sORFs). They then synthesised the predicted peptide, demonstrated its presence in human plasma, and reported its metabolic effects in mice on a high-fat diet.

The broader context is the emerging concept of mitochondrial-derived peptides (MDPs) — short peptides translated from mitochondrial DNA sORFs that act as signalling molecules between mitochondria and the nucleus. Humanin was the first MDP identified; MOTS-c, SHLPs, and others followed.

Preclinical pathways

  1. AMPK activation. MOTS-c treatment has been reported to activate the AMPK pathway in skeletal muscle and adipose tissue, producing effects that resemble the metabolic signature of exercise — improved glucose uptake, fatty-acid oxidation, and mitochondrial biogenesis.
  2. Insulin sensitisation. In diet-induced obese mice and in age-related insulin resistance models, MOTS-c has been shown to improve insulin sensitivity and glucose tolerance.
  3. Exercise adaptation. Reynolds et al. (Nature Communications 2021) reported that MOTS-c levels rise with exercise and that exogenous MOTS-c preserves physical performance in ageing mice.

Storage

Store lyophilised MOTS-c at −20°C. Once reconstituted, refrigerate at 2–8°C and use within 2–4 weeks.

Frequently asked questions

What is MOTS-c?
MOTS-c (Mitochondrial ORF of the 12S rRNA type-c) is a 16-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA gene. It is a member of a growing class of "mitochondrial-derived peptides" that act as mitochondrial-to-nuclear messengers regulating metabolism and stress adaptation.
How was MOTS-c discovered?
MOTS-c was identified by Lee et al. in 2015 through bioinformatic scanning of the mitochondrial genome for small open reading frames. They showed that the peptide circulates in human plasma and that its levels decline with age, making it a candidate biomarker and therapeutic target for age-related metabolic dysfunction.
What pathways does MOTS-c affect?
The most-cited pathway is AMPK signalling. In skeletal muscle and adipose tissue, MOTS-c has been reported to activate AMPK, promote insulin sensitivity, and produce exercise-like metabolic adaptations. Preclinical rodent studies have examined effects on high-fat-diet-induced obesity and on age-related insulin resistance.
What is MOTS-c's molecular weight?
MOTS-c has a molecular weight of 2,174.58 g/mol and a molecular formula of C100H152N24O22S. Its sequence is Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg.

References

  1. [1]Lee C, Zeng J, Drew BG, et al.. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 2015. DOI: 10.1016/j.cmet.2015.02.009
  2. [2]Reynolds JC, Lai RW, Woodhead JST, et al.. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline. Nature Communications, 2021. PMID: 33658471
  3. [3]National Center for Biotechnology Information. PubChem CID 91826424 — MOTS-c, 2024

Related research